Posted on March 31st, 2011 by Health News
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
While the median age at diagnosis for chronic myeloid leukemia is over 60 years old and incidence increases dramatically with age,limited data are available about the long-term outcome for older patients treated with imatinib, the standard first-line therapy used to treat CML.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
Speaking at the UK National Stem Cell Network conference in York later today, Professor Tessa Holyoake from the University of Glasgow will discuss a brand new approach to treating chronic myeloid leukaemia in which a small number of cancer cells persist despite effective therapy thus preventing cure.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
CEL-SCI Corporation announced today that the State of Israel’s Ministry of Health has given approval to begin enrollment of subjects for a Phase III clinical trial of Multikine in Israel.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
The drug boceprevir helps cure hard-to-treat hepatitis C, says Saint Louis University investigator Bruce R. Bacon, M.D., author of the March 31 New England Journal of Medicine article detailing the study’s findings.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
Amgen announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in March by the Committee For Medicinal Products for Human Use (CHMP) for the use of Vectibix in combination with chemotherapy for patients with wild-type KRAS metastatic colorectal cancer (mCRC).
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the [...]
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
No Comments »
Filed under: Pharmacy News
Posted on March 31st, 2011 by Health News
Amgen, Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Company Limited today announced top-line results from the MONET1 pivotal Phase 3 trial evaluating motesanib administered in combination with paclitaxel and carboplatin in 1,090 patients with advanced non-squamous non-small cell lung cancer.
No Comments »
Filed under: Pharmacy News
